Important Safety Information: CAPRELSA® (vandetanib) Tablets can
cause a change in the electrical activity of your heart called QT prolongation, which can cause
irregular heartbeats and that may lead to death. You should not take CAPRELSA if you have had a
condition called long QT syndrome since birth. View
Sanofi Genzyme respects individual privacy and values the confidence of its customers, partners,
patients and employees.
regarding the collection, use and disclosure of information that you may provide through this site.
Whenever you submit information through this site to Genzyme, you agree with the terms of Sanofi
information through this website. By selecting "continue" you are agreeing to the terms of Sanofi
You are leaving caprelsa.com, a website of Genzyme Corporation. Genzyme Corporation does not review
or control the content of non-Genzyme websites, and this hyperlink does not constitute an
endorsement by Genzyme of the site’s content. Genzyme’s privacy procedures do not apply to the
owners of a non-Genzyme website.